Status:
RECRUITING
The Role of B7-H4 in Tumor Vaccine
Lead Sponsor:
Huashan Hospital
Conditions:
Glioma
Eligibility:
All Genders
18-80 years
Brief Summary
Glioma patients have poor prognosis because of limited choices of treatment. Therapeutic cancer vaccines have been proved to improve survival in glioma, but resistance is a new challenge for vaccine t...
Eligibility Criteria
Inclusion
- The patients with glioma in the Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University who meet the following three conditions can be enrolled
- They were 18-80 years old, male and female;
- The pathological results of frozen section during operation were gliomas;
- Tissue (6 mm \* 6 mm) can be used for cell sorting on the basis of not affecting clinical routine diagnosis;
- Sign informed consent.
Exclusion
- Patients who meet any of the following criteria will not be included in this study:
- Participants in other clinical trials;
- Pregnant women.
Key Trial Info
Start Date :
November 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06156150
Start Date
November 26 2023
End Date
December 31 2026
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Di Chen
Shanghai, Shanghai Municipality, China, 200040